The Clinical Core of the Alzheimer's Disease Neuroimaging Initiative (ADNI) has provided
clinical, operational, and data management support to ADNI since its inception. This article …

The Alzheimer's Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-year
research project that studies changes of cognition, function, brain structure and function, …

Objective: To compare the diagnostic accuracy of CSF biomarkers and amyloid PET for
diagnosing early-stage Alzheimer disease (AD). Methods: From the prospective, longitudinal …

Importance Plasma phosphorylated tau at threonine 181 (p-tau181) has been proposed as
an easily accessible biomarker for the detection of Alzheimer disease (AD) pathology, but its …

Ischemia-reperfusion (I/R) is an important cause of acute renal failure (ARF). The complement
system appears to be essentially involved in I/R injury. However, via which pathway the …

Aberrant connectivity is implicated in many neurological and psychiatric disorders, including
Alzheimer’s disease and schizophrenia. However, other than a few disease-associated …

Calcitonin gene‐related peptide ( CGRP ) is a ubiquitous neuropeptide found at the very
centers of the migraine process, both centrally and peripherally. It has been under careful study …

Slowing the progression of Alzheimer disease (AD) might be the greatest unmet medical
need of our time. Although one AD therapeutic has received a controversial accelerated …

Objective: To investigate the vascular contribution to longitudinal changes in Alzheimer
disease (AD) biomarkers. Methods: The Alzheimer's Disease Neuroimaging Initiative is a clinic …

Objective: To examine sex differences in the relationship between clinical symptoms related
to Alzheimer disease (AD) (verbal memory deficits) and neurodegeneration (hippocampal …